Related Experiment Video
Updated: Aug 16, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
DNA-based tumor vaccines
1Medizinische Klinik und Poliklinik II, Onkologie und Hämatologie, Charité der Humboldt Universität, Berlin. gabriele.pescher@charite.de
Abstract:
Tumor vaccination strategies have been increased over the past years. This increase began with the identification of tumor antigens recognized by the immune system. Better understanding of the immune system and increasing knowledge about the antigen presentation process and the role of dendritic cells have opened new therapeutic possibilities. DNA vaccines, already successfully used against viral antigens and covering a broad repertoire of epitopes, might also be of advantage in tumor immunotherapy. Design and selection of vectors are of considerable importance for the vaccination. There are three major types of DNA-based recombinant cancer vaccines: DNA from tumor antigens can be used 1) to modify dendritic cells, 2) as 'naked' DNA-vaccine or 3) to construct recombinant viral vaccines. The current status in this field is shown and different vaccination strategies are discussed.
Insights
DNA vaccines offer promising avenues for cancer immunotherapy by targeting tumor antigens. Research explores DNA vaccines, including modified dendritic cells and recombinant viral vaccines, for enhanced cancer treatment strategies.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Tumor vaccination strategies have advanced due to identifying tumor antigens and understanding immune system functions.
- Enhanced knowledge of antigen presentation and dendritic cell roles has created new therapeutic avenues.
- DNA vaccines, effective against viral antigens, show potential for cancer immunotherapy.
Purpose of the Study:
- To review the current status of DNA-based cancer vaccines.
- To discuss various vaccination strategies utilizing DNA technology for cancer treatment.
- To highlight the importance of vector design in DNA cancer vaccines.
Main Methods:
- Review of existing literature on tumor antigens and immune system interactions.
- Analysis of DNA vaccine technologies, including dendritic cell modification, naked DNA vaccines, and recombinant viral vaccines.
- Discussion of vector selection and design considerations for cancer immunotherapy.
Main Results:
- Identification of tumor antigens has spurred advancements in cancer vaccination.
- DNA vaccines present a versatile platform for tumor immunotherapy.
- Three primary types of DNA-based recombinant cancer vaccines have been identified.
Conclusions:
- DNA vaccines hold significant potential for advancing cancer immunotherapy.
- Strategic design and selection of vectors are crucial for effective DNA cancer vaccines.
- Further research into DNA-based vaccination strategies may lead to improved cancer treatments.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

